Compare IND. SWIFT with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IND. SWIFT vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IND. SWIFT DR. REDDYS LAB IND. SWIFT/
DR. REDDYS LAB
 
P/E (TTM) x -2.5 40.5 - View Chart
P/BV x - 4.4 - View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 IND. SWIFT   DR. REDDYS LAB
EQUITY SHARE DATA
    IND. SWIFT
Mar-21
DR. REDDYS LAB
Mar-21
IND. SWIFT/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs55,515 0.1%   
Low Rs23,028 0.1%   
Sales per share (Unadj.) Rs65.71,145.4 5.7%  
Earnings per share (Unadj.) Rs-5.5114.5 -4.8%  
Cash flow per share (Unadj.) Rs0.5188.4 0.3%  
Dividends per share (Unadj.) Rs025.00 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs-128.41,053.2 -12.2%  
Shares outstanding (eoy) m54.16166.30 32.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.13.7 1.4%   
Avg P/E ratio x-0.637.3 -1.7%  
P/CF ratio (eoy) x6.422.7 28.2%  
Price / Book Value ratio x04.1 -0.7%  
Dividend payout %021.8 0.0%   
Avg Mkt Cap Rs m184710,289 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m51236,299 1.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,561190,475 1.9%  
Other income Rs m1522,914 5.2%   
Total revenues Rs m3,713193,389 1.9%   
Gross profit Rs m40238,699 1.0%  
Depreciation Rs m32712,288 2.7%   
Interest Rs m522970 53.8%   
Profit before tax Rs m-29528,355 -1.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m39,319 0.0%   
Profit after tax Rs m-29819,036 -1.6%  
Gross profit margin %11.320.3 55.5%  
Effective tax rate %-1.132.9 -3.3%   
Net profit margin %-8.410.0 -83.8%  
BALANCE SHEET DATA
Current assets Rs m2,652145,503 1.8%   
Current liabilities Rs m7,06281,038 8.7%   
Net working cap to sales %-123.933.8 -365.9%  
Current ratio x0.41.8 20.9%  
Inventory Days Days15361 249.5%  
Debtors Days Days1,10795 1,163.3%  
Net fixed assets Rs m4,064109,979 3.7%   
Share capital Rs m108832 13.0%   
"Free" reserves Rs m-7,060174,319 -4.1%   
Net worth Rs m-6,952175,151 -4.0%   
Long term debt Rs m6,4426,299 102.3%   
Total assets Rs m6,716255,482 2.6%  
Interest coverage x0.430.2 1.4%   
Debt to equity ratio x-0.90 -2,576.6%  
Sales to assets ratio x0.50.7 71.1%   
Return on assets %3.37.8 42.5%  
Return on equity %4.310.9 39.5%  
Return on capital %-44.516.2 -275.2%  
Exports to sales %74.251.3 144.7%   
Imports to sales %5.018.1 27.4%   
Exports (fob) Rs m2,64397,699 2.7%   
Imports (cif) Rs m17634,420 0.5%   
Fx inflow Rs m2,68297,699 2.7%   
Fx outflow Rs m26034,420 0.8%   
Net fx Rs m2,42263,279 3.8%   
CASH FLOW
From Operations Rs m77235,703 2.2%  
From Investments Rs m-167-22,660 0.7%  
From Financial Activity Rs m-483-298 162.1%  
Net Cashflow Rs m12212,858 1.0%  

Share Holding

Indian Promoters % 24.1 26.7 90.2%  
Foreign collaborators % 31.5 0.0 -  
Indian inst/Mut Fund % 0.0 49.2 -  
FIIs % 0.0 27.8 -  
ADR/GDR % 0.0 12.1 -  
Free float % 44.5 61.2 72.6%  
Shareholders   12,424 255,720 4.9%  
Pledged promoter(s) holding % 68.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IND. SWIFT With:   OMKAR PHARMACHEM  MEDICAMEN BI  GUJ.THEMIS.  RAYMED LABS  LUPIN  



Today's Market

5 Reasons Why Sensex Plunged 765 Points Today(Closing)

It was a volatile day for Indian share market today. After opening the day in green, benchmark indices erased gains within the first hour and kept falling as the session progressed.

Related Views on News

Dr Reddy's New Covid-19 Treatment Option Puts Stock in Focus (Views On News)

May 24, 2021

With the second wave pushing up sales of medicines, Indian pharma companies are likely to see traction in their volumes.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IND. SWIFT SHARE PRICE


Dec 3, 2021 (Close)

TRACK IND. SWIFT

  • Track your investment in IND. SWIFT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE IND. SWIFT WITH

MARKET STATS